Healthcare Equipment and Supplies
Company Overview of One Lambda, Inc.
One Lambda, Inc. provides HLA products. It offers serological products and reagents, such as Terasaki HLA tissue typing trays, monoclonal typing trays, cell isolation reagents, HLA testing reagents, specialty products, and accessories. The company also provides molecular products, such as DNA testing technologies, sequence specific primer, and reverse sequence specific oligonucleotide. In addition, it offers antibody detection products; and C1qScreen, HNA genotyping trays, bulk primer sets, cytokine genotyping, KIR SSO genotyping tests, and bulk monoclonal antibodies. Further, the company provides automation products that allow laboratories to automate reagent dispensing and tray evaluation ...
21001 Kittridge Street
Canoga Park, CA 91303-2801
Founded in 1984
Key Executives for One Lambda, Inc.
Co-Founder and Chairman of the Board
Vice President of Operations
Vice Chair of the Board and Secretary
Compensation as of Fiscal Year 2013.
One Lambda, Inc. Key Developments
One Lambda, Inc. Obtains United States Food and Drug Administration Clearance for HLA Fusion Software Version 3.0
Jan 23 13
One Lambda, Inc. announced that HLA Fusion Software version 3.0, a companion software to molecular typing and antibody screening products, has obtained FDA clearance by the United States Food and Drug Administration and a Health Canada License by the Ministry of Health Canada. All of the company's software products are designed to assist personnel experienced in HLA analysis by suggesting typing and antibody screening results. Product families used in conjunction with HLA Fusion include the market-leading LABScreen (antibody detection) and LABType (HLA Typing) products, in addition to LAT, LCT, FlowPRA, and MicroSSP products. The HLA Fusion Software version 3.0 provides all the tools and applications from version 2.0 and its related Service Packs, support with Luminex xPONENT 3.1 acquisition software for LABScan 100, and more.
One Lambda, Inc., Thermo Fisher Scientific, Inc. - M&A Call
Jul 16 12
To discuss the acquisition of One Lambda for $925 million in cash, subject to a post-closing adjustment
One Lambda, Inc. and Celltrend GmbH Enter into Supply Agreement
Jun 15 12
One Lambda, Inc. announced that it has forged a partnership with Celltrend GmbH to advance its outreach to the global transplant community. This new alliance is part of a supply agreement, giving One Lambda, Inc. worldwide exclusivity to distribute the Immuno-Assay product, EIA for Quantitative Determination of anti-Angiotensin II Receptor 1 (AT1)-Antibodies. This ELISA based application screens antibodies that form against Angiotensin II Type I Receptors (AT1R).
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|